Article Information
PubMed
Published By
History
- Received November 29, 2017
- Revision received February 6, 2018
- Accepted February 7, 2018
- Published online March 5, 2018.
Copyright & Usage
Copyright © 2018 Sheahan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Author Information
- Tayler D. Sheahan1,2,
- Manouela V. Valtcheva1,2,
- Lisa A. McIlvried1,
- Melanie Y. Pullen1,
- David A.A. Baranger2,3 and
- Robert W. Gereau IV1
- 1Washington University Pain Center and Department of Anesthesiology, Washington University School of Medicine, St. Louis, Missouri 63110
- 2Washington University Program in Neuroscience, Washington University School of Medicine, St. Louis, Missouri 63110
- 3BRAIN Laboratory, Department of Psychological and Brain Sciences, Washington University in St. Louis, St. Louis, Missouri 63130
- Correspondence should be addressed to Robert W. Gereau IV, PhD, Director | Washington University Pain Center, Dr. Seymour and Rose T. Brown Professor, Department of Anesthesiology, Washington University School of Medicine, 660 S. Euclid Avenue, Campus Box 8054, St. Louis, MO 63110, Telephone number: (314) 362-8312, Fax Number: (314) 362-8334, E-mail: gereaur{at}wustl.edu.
Author contributions
Author contributions: T.D.S. and R.W.G. IV designed research; T.D.S., M.V.V., L.A.M., and M.Y.P. performed research; T.D.S. and D.A.A.B. analyzed data; T.D.S. wrote the paper.
Disclosures
The authors declare no competing financial interests.
Conflict of Interest: Authors report no conflict of interest.
This work was supported by NINDS R01NS042595 to RWG, NINDS F31NS089130 to MVV, NIDA 2T32 DA007261-26 to LAM, and NSF DGE1745038 to DAAB.
Funding
HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
R01NS042595; F31NS089130HHS | NIH | National Institute on Drug Abuse (NIDA)
2T32 DA007261-26NSF | EHR | Division of Graduate Education (DGE)
DGE1745038
Other Version
- previous version (March 05, 2018).
- You are viewing the most recent version of this article.
Online Impact
Article usage
In this issue
Metabotropic Glutamate Receptor 2/3 (mGluR2/3) Activation Suppresses TRPV1 Sensitization in Mouse, But Not Human, Sensory Neurons
